Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study

por Weng JJ, Wang LH, Zhu H, Xu WR, Wei YM, Wang ZY, Yu WJ, Li HF
Publicado 2019

Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity

por Liu Y, Piao HY, Gao Y, Xu CH, Tian Y, Wang LH, Liu JW, Tang B, Zou MJ, Cheng G
Publicado 2015